Session · US equities

2026-8-19 (Wed)

US common stocks / ADRs: top 10 by volume; top 10 gainers (by % change, volume as tie-breaker); top 10 losers (by % change, prefer liquid names). Deep notes cover the de-duplicated set across the three boards.

29 names on this page · volume 10 · gainers 10 · losers 10

1. Top 10 by volume (10)

RankTickerNameClose% ChgVolume
1/10 MRNA MRNA 174.38 +176.97% 193.90M
2/10 INTC INTC 92.80 -4.02% 109.30M
3/10 NU NU 14.61 +1.81% 102.70M
4/10 AAL AAL 13.86 -1.35% 97.50M
5/10 NVDA NVDA 217.56 -0.99% 96.20M
6/10 WBS WBS 77.57 -0.51% 91.30M
7/10 NOK NOK 10.13 -2.50% 79.50M
8/10 SPCX SPCX 139.65 -2.57% 75.60M
9/10 SAN SAN 14.17 -0.49% 73.50M
10/10 BMNR BMNR 20.24 +10.72% 73.30M

2. Top gainers (10)

RankTickerNameClose% ChgVolume
1/10 MRNA MRNA 174.38 +176.97% 193.90M
2/10 TNON TNON 11.41 +109.36% 49.20M
3/10 RDAC RDAC 8.78 +50.09% 16.30M
4/10 UUU UUU 6.24 +38.05% 243.6K
5/10 SKK SKK 5.73 +36.43% 7.80M
6/10 PURR PURR 9.39 +30.42% 58.90M
7/10 MRVI MRVI 7.22 +25.78% 15.10M
8/10 ARCT ARCT 10.28 +25.21% 5.60M
9/10 TEM TEM 61.25 +24.09% 22.40M
10/10 NIPG NIPG 14.71 +23.20% 155.3K

3. Top losers (10)

RankTickerNameClose% ChgVolume
1/10 PFSA PFSA 13.57 -50.62% 1.40M
2/10 IPST IPST 8.45 -46.38% 1.90M
3/10 KWM KWM 1.64 -37.88% 1.00M
4/10 WETO WETO 20.76 -37.09% 964.4K
5/10 SNSC SNSC 1.31 -35.47% 707.5K
6/10 XOS XOS 2.90 -34.68% 7.60M
7/10 SLE SLE 4.12 -25.09% 1.70M
8/10 TOYO TOYO 4.34 -24.21% 4.80M
9/10 WYFI WYFI 21.38 -21.02% 15.70M
10/10 CAST CAST 1.70 -19.05% 41.80M

Stock notes (de-duplicated)

Order: volume board → gainers → losers; each ticker appears once. Summaries of public information only — please verify primary sources.

1/10 MRNA MRNA +176.97%

Close 174.38 · Vol 193.90M · Type: Other

MRNA MRNA
Approx. 1-month price (illustrative)

Business Moderna, Inc. (NASDAQ: MRNA) is a Cambridge, Massachusetts-based biotechnology company pioneering messenger RNA (mRNA)-based medicines and vaccines, with products including Spikevax (COVID-19), mRESVIA (RSV), mFLUSIVA (influenza), and a deep oncology pipeline. The company is developing personalized mRNA neoantigen cancer therapies in partnership with Merck.

Today’s take On August 19, 2026, Moderna and Merck announced positive Phase 3 (INTerpath-001) topline results for intismeran autogene (mRNA-4157/V940), an mRNA-based individualized neoantigen therapy, combined with KEYTRUDA in 1,137 patients with completely resected stage IIB-IV melanoma. The trial met its primary endpoint of recurrence-free survival (RFS) and key secondary endpoint of distant metastasis-free survival (DMFS), both statistically significant vs. KEYTRUDA alone — the first positive Phase 3 readout for any individualized neoantigen therapy or mRNA-based cancer therapy. Shares surged +176.97% to $174.38 from $62.96, adding roughly $44B in market cap (~$25B to ~$69.6B). The move was amplified by a short squeeze: short interest was ~13-14% of free float (~49.8M shares), with short sellers losing an estimated $4.8-5.5B in a single session. William Blair upgraded MRNA to Outperform, and the read-through boosted the Nasdaq Biotech index +4.4% and peers (BioNTech +22%, Novavax +10.8%). The results set the stage for regulatory filings and could mark Moderna's first oncology approval.

2/10 INTC INTC -4.02%

Close 92.80 · Vol 109.30M · Type: Sector

INTC INTC
Approx. 1-month price (illustrative)

Business Intel Corporation (NASDAQ: INTC), headquartered in Santa Clara, California, designs and manufactures advanced semiconductors that power client computing, data center, and AI workloads. It operates through segments including Client Computing (CCG), Data Center & AI (DCAI), and Intel Foundry (wafer fabrication and external foundry services), employing ~85,100 people. Intel is a Delaware-incorporated company listed on NASDAQ Global Select Market.

Today’s take On Aug 19, 2026, Intel fell 4.02% to close at $92.80 (day range $91.28-$98.20) as part of a continuing, broad semiconductor/memory-chip sector selloff rather than any single negative INTC-specific headline. The prior session (Aug 18) had crushed storage/memory names - SK Hynix ADR -9.2%, Micron -7.0%, SanDisk/Seagate -9%, Western Digital -7.4% - with Intel itself down 6.58%. The pressure persisted into Aug 19 as the Philadelphia Semiconductor Index slid ~2%, with AMD, Broadcom, and ARM falling alongside. Multiple factors amplified the decline: (1) Intel had just raised $20B in an upsized common-stock offering priced at $95/share (210.5M shares, closed Aug 12), the largest in its history, and the stock broke below that offering price; BofA estimated ~4-5% EPS dilution from the ~4X-higher share count. (2) The share price had rallied ~162% YTD / ~293% TTM to rich levels, trading at ~56-62x forward earnings, making it a prime profit-taking target. (3) Macro pressure from rising Treasury yields and surging oil prices (amid the US-Iran conflict) triggered risk-off de-risking in high-beta AI chips.

3/10 NU NU +1.81%

Close 14.61 · Vol 102.70M · Type: Other

NU NU
Approx. 1-month price (illustrative)

Business Nu Holdings Ltd. (NYSE: NU) is a Cayman Islands-incorporated holding company that operates Nubank, the largest digital financial services platform in Latin America. Founded in 2013 by Colombian entrepreneur David Vélez and headquartered in São Paulo, Brazil, Nu provides digital banking products including credit cards, unsecured personal loans, savings and deposit accounts, high-yield savings, investment products, and payment solutions across Brazil, Mexico, Colombia, and the United States. As of Q2 2026, Nu serves roughly 139 million customers (118 million in Brazil) with a credit portfolio of $39.4 billion, supported by $45.3 billion in deposits. Class A shares trade on the NYSE with a market capitalization of approximately $69-71 billion.

Today’s take NU closed at $14.61 on August 19, 2026, up +1.81%, as the stock rebounded following a two-session pullback after one of the most significant earnings reactions in company history. Q2 2026 results were released after the market close on Thursday, August 13, revealing record net income of $1.06 billion (first time exceeding $1 billion in a single quarter, beating consensus by 9.6%), revenue of $5.88 billion (beating by ~5%), and a risk-adjusted net interest margin that surged 290 basis points to 12.4% from 9.5% in Q1—exceeding even the most bullish analyst benchmarks around 11%. Shares jumped roughly 9.3% on August 14 to $15.23 on 156 million shares, then corrected -3.22% on August 17 and -2.65% on August 18 as investors digested credit concerns (90+ day delinquencies rose to 6.9% from 6.5%) and management's caution that part of the credit-cost improvement was seasonal. The August 19 session represented continued post-earnings digestion: the stock opened at $14.43, rallied to an intraday high of $14.99, and settled at $14.61 as buy-side conviction on the margin-rebound narrative was reinforced by circulating analyst research from Goldman Sachs (Buy, $22), JPMorgan ('solid beat', $20)

4/10 AAL AAL -1.35%

Close 13.86 · Vol 97.50M · Type: Sector

AAL AAL
Approx. 1-month price (illustrative)

Business American Airlines Group, Inc. (NASDAQ: AAL) is a Delaware-registered holding company and one of the world's largest legacy network air carriers by passenger volume and fleet size. Through its mainline subsidiary American, it operates scheduled passenger and cargo service across domestic, Latin America, Atlantic and Pacific routes with hubs in Dallas/Fort Worth, Charlotte, Chicago, Miami, New York, Philadelphia, Phoenix and Washington D.C. Regional service runs through American Eagle affiliates (Envoy, PSA, Piedmont).

Today’s take AAL fell 1.35% to $13.86 on Aug 19, 2026, a fifth straight down session (-7.2% cumulative), as a broad airline selloff hit the sector. The primary catalyst was macro-commodity pressure: Brent crude rose for a fourth consecutive session to ~$91.28/barrel amid continued Strait of Hormuz geopolitical risk and closed Middle East airspace, lifting jet-fuel costs and compressing airline margins. AAL declined less than its large U.S. peers (DAL -2.81%, UAL -2.48%, LUV -2.52%) partly because, as an unhedged airline, it carries the greatest upside leverage if fuel prices reverse (every 1 cent/gal shift ≈ $45M annual expense; a 10-cent swing ≈ $450M, ~4.9% of market cap). Compounding the tape was a persistent negative analyst backdrop following record Q2 revenue ($16.7B) but fuel expense surging +83% ($2.2B), with Goldman cutting target to $13 (Sell), BofA to $17, and Citi to $19, plus Zacks trimming Q3 EPS estimates.

5/10 NVDA NVDA -0.99%

Close 217.56 · Vol 96.20M · Type: Other

NVDA NVDA
Approx. 1-month price (illustrative)

Business NVIDIA Corporation, listed on the NASDAQ, is the world's leading designer of graphics processing units (GPUs) and accelerated computing platforms. Its data-center and AI chips, including the H200 and Blackwell family, power artificial intelligence training and inference across cloud, enterprise, and sovereign AI deployments.

Today’s take On Aug 19, 2026 (Wednesday US session), NVDA fell 0.99% to close at $217.56 (open 221.67, high 222.87, low 216.76) — a second straight down day after dropping 2.34% on Aug 18. The catalyst was macro-driven: US long bond yields hit multi-decade highs (30-yr ~5.33%, a 19-year high; 10-yr ~4.38-4.69%) as crude firmed near $91/bbl (Brent) amid the US-Iran conflict after President Trump ruled out reviving a truce. Higher discount rates compressed the priciest AI/chip equities; the SOX fell ~3.7-5% on Aug 18 with peers Micron -7%, AMD -4.3%, Broadcom -3.2%. On Aug 19, semiconductor pressure persisted (Broadcom -4.84%, Intel -3.99%, AMD -3.42%) and the Nasdaq lagged even as the Dow rose 0.64%, while July FOMC minutes landed that afternoon. A Financial Times report that NVDA's H200 chip was cleared for limited China-market entry (ByteDance, Tencent ~10k units each) capped losses and lifted premarket. Next catalyst: earnings due ~Aug 26.

6/10 WBS WBS -0.51%

Close 77.57 · Vol 91.30M · Type: Other

WBS WBS
Approx. 1-month price (illustrative)

Business Webster Financial Corporation (NYSE: WBS) is the Stamford, Connecticut-based bank holding company for Webster Bank, N.A., a national commercial bank serving individuals, families and businesses through Consumer, Commercial and Healthcare Financial Services segments. Founded in 1935, it is one of the most efficient deposit-gathering retail/commercial banks in the U.S. Northeast.

Today’s take August 19, 2026 was effectively the final trading session for WBS ahead of its acquisition by Banco Santander (SAN), with the deal scheduled to close August 20. This is a pure merger-arbitrage/pre-settlement session, not a fundamental catalyst. Under the terms, each Webster share receives $48.75 cash plus 2.0548 Santander ADS. With SAN closing at $14.17, the floating share leg implied ~$29.12, giving total consideration of ~$77.87 — WBS closed at $77.57, only ~$0.30 (~0.38%) below deal value. The -0.51% drop was largely a passthrough of SAN's own decline (-0.49%), since the stock-for-stock consideration moves with Santander. The Fed approved the deal August 4 (following OCC and ECB clearances), and S&P Dow Jones was removing WBS from the S&P MidCap 400 (replaced by Sun Communities) while options exchanges (MIAX) were delisting WBS effective August 20 — forcing index funds and arbitrageurs to settle and exit, compressing the spread to near-zero. Volume surged ~19.7x.

7/10 NOK NOK -2.50%

Close 10.13 · Vol 79.50M · Type: Other

NOK NOK
Approx. 1-month price (illustrative)

Business Nokia Oyj (NYSE: NOK) is a Finnish multinational telecommunications, networking, and technology company headquartered in Espoo, Finland. It supplies mobile and fixed-network equipment, optical and IP routing gear, and AI data-center infrastructure to operators and cloud providers worldwide.

Today’s take On August 19, 2026, Nokia's ADR closed at $10.13, down -2.50%, after opening higher at $10.71 (roughly +2% pre-market) and fading through the session to an intraday low of $10.09. This was the second straight session of selling following the August 18 China-exit news, when the stock dropped -3.62% to $10.39 on 107.9M shares after reports (SCMP, Light Reading) said Nokia would close almost all mainland-China sites and cut about 1,600 Hangzhou R&D jobs by year-end, a near-total retreat after 40 years. At stake: Greater China contributed only 4.6% of 2025 sales (EUR 913M, down from 7.9% in 2019), but Nokia expects ~EUR 350M in 2026 China integration charges against ~EUR 200M in annual savings. Q2 2026 fundamentals remain solid (net sales +8% to EUR 4.815B, comparable op profit +18% to EUR 434M, reported EUR 50M loss, AI & Cloud sales +105%). The Aug 19 fade added to the June-to-August drawdown from a $17+ peak, with $10 now a key technical support; the stock trades below the 50-day SMA ($11.55) but above the 200-day SMA ($9.40). Analyst backdrop is bullish (JPMorgan Overweight, consensus target ~$15-18).

8/10 SPCX SPCX -2.57%

Close 139.65 · Vol 75.60M · Type: Other

SPCX SPCX
Approx. 1-month price (illustrative)

Business Space Exploration Technologies Corp. (SPCX) is the publicly traded parent of SpaceX, the private rocketry and satellite firm, listed on the NASDAQ. It operates the Starlink satellite internet constellation, launches commercial and government cargo/crew missions, and is expanding into AI infrastructure following its $60B acquisition of AI coding tool Cursor.

Today’s take SPCX fell $3.69 (-2.57%) to $139.65 on Aug 19, 2026, extending weakness ahead of a major supply event: ~319 million insider/employee shares (the 'Day 70' tranche of a staggered post-IPO lockup) became eligible to trade on Aug 20, part of a release curve that frees ~88% of 13.18B shares through 2027. With a float of only ~204M shares and insiders holding ~46%, the imminent unlock created a sharp supply-overhang, so the market sold into the close. Compounding pressure: China's LandSpace recovered the first stage of its reusable Zhuque-3 rocket on Aug 19, narrowing SpaceX's reusability moat; Bloomberg reported SpaceX approached AI coding startup Cognition AI (talks inactive), raising AI capex-spending concerns; and NYU's Scott Galloway publicly argued the stock is only worth $10-30, far below the $143.34 prior close. The stock also gave back gains from a strong post-IPO rally (52-week range $104.83-$225.64) and recent Google/Nvidia stake disclosures. Note: volume ~69-75.6M was actually below the 20-day average of ~115M, indicating orderly distribution rather than panic capitulation.

9/10 SAN SAN -0.49%

Close 14.17 · Vol 73.50M · Type: Other

SAN SAN
Approx. 1-month price (illustrative)

Business Banco Santander, S.A. (NYSE: SAN) is Spain's largest bank and one of Europe's most valuable financial institutions, operating a universal retail and commercial banking model across nine core markets in Europe and the Americas. Listed as a Sponsored ADR on the NYSE with primary listing on the Bolsa de Madrid, the bank serves over 182 million customers through five global businesses: Retail & Commercial Banking, Digital Consumer Bank, Corporate & Investment Banking, Wealth Management & Insurance, and Payments.

Today’s take On August 19, 2026, SAN closed at $14.17, down 0.49%, on ~73.5M shares — roughly 7x its normal ~10M average volume. The dominant catalyst was the $12.2B Webster Financial acquisition set to close the following day (August 20, 2026), following Federal Reserve approval on August 4. Webster shareholders receive $48.75 cash plus 2.0548 Santander ADS per share, with Santander issuing ~335M new shares. On the final pre-close session, WBS volume soared 19.7x its average while the merger spread tightened to just 0.38%. Both stocks fell nearly the same percentage (-0.51% WBS vs -0.49% SAN), consistent with the floating share leg of the deal structure. The move also reflected broader European banking weakness: the Ibex 35 lost the 19,900 level with Santander's Madrid-listed shares down ~1.2-1.7% and Spanish banks broadly lower as sovereign bond buying fell. Arbs and institutional desks locked in final deal value, while Webster shareholders holding the ADS share-leg were expected to sell into the open market upon issuance.

10/10 BMNR BMNR +10.72%

Close 20.24 · Vol 73.30M · Type: Sector

BMNR BMNR
Approx. 1-month price (illustrative)

Business Bitmine Immersion Technologies, Inc. (NYSE: BMNR), formerly Sandy Springs Holdings, is a Las Vegas-based blockchain technology company that acquires, holds and actively manages Ethereum (ETH) as its primary corporate treasury reserve asset. It runs ETH treasury/staking operations (5.82M ETH held, ~4.8% of circulating supply, worth ~$11.4B in total crypto/cash/strategic investments), provides Bitcoin ecosystem services (consulting, equipment leasing, power/hosting facilitation), and holds strategic stakes in Beast Industries and Eightco Holdings.

Today’s take Aug 19, 2026 was a broad crypto-sector momentum event rather than a BMNR-specific fundamental catalyst. BMNR closed at $20.24, up $1.96 (+10.72%), after hitting an intraday high of $20.90 (+13.35%). The primary driver was the U.S. SEC formally proposing 'Regulation Crypto Assets' on Aug 19, creating a tailored digital-asset securities framework with two offering exemptions ($5M over four years; $75M per 12-month period) — a major sentiment boost for all crypto-exposed equities. On the same day, Bitcoin surged ~6% past $68,000 (touching $69,000+), Ethereum rallied ~9% above $2,000, and about $1.4B in bearish crypto derivative positions were liquidated, triggering a short squeeze. Macro fuel came from Treasury Secretary Scott Bessent doubling U.S. bond buyback operations (boosting risk liquidity), plus optimism over the CLARITY Act with a Senate procedural vote scheduled for Sept 15. BMNR also had a momentum backdrop from its Aug 17 disclosure of adding 9,926 ETH (14th straight weekly purchase), total 5.82M ETH, ~$11.4B holdings, and a 1.7M-share repurchase (20.8M cumulative). BMNR remains deeply negative YTD (down ~33-39%), so this rally is a high-beta sector short-squeeze rebound.

2/10 TNON TNON +109.36%

Close 11.41 · Vol 49.20M · Type: Squeeze / float

TNON TNON
Approx. 1-month price (illustrative)

Business Tenon Medical, Inc. (NASDAQ: TNON) is a micro-cap medical device company headquartered in Los Gatos, California, focused on minimally invasive sacroiliac (SI) joint fusion. Its primary commercial products are the Catamaran SI Joint Fusion System and the SImmetry+ sacral pelvic platform, targeting lower-back pain from SI joint disorders.

Today’s take TNON surged ~109% on 2026-08-19 to close at $11.41 after the company received a USPTO Notice of Allowance for a patent titled 'Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints' (announced late 8/18 into 8/19). The patent validates the core IP behind its SI-joint fixation platform, providing commercial defense against rivals at a time when the company is funding operations via aggressive dilution. The stock had already climbed +10.8% on 8/18 on 3.4M shares (vs ~40K typical), setting up a momentum-accelerated short squeeze the following day. On 8/19 the stock spiked to an intraday high of $17.84 (+227%) before closing at $11.41. Contextual headwinds remain: a 1-for-35 reverse split (effective 8/10/26), a $100M shelf registration plus $4.4M ATM program, and a Q2 miss (revenue $1.28M vs $1.54M consensus; EPS -$12.35 vs -$8.40 expected).

3/10 RDAC RDAC +50.09%

Close 8.78 · Vol 16.30M · Type: Squeeze / float

RDAC RDAC
Approx. 1-month price (illustrative)

Business Rising Dragon Acquisition Corp. (NASDAQ: RDAC) is a Cayman Islands special purpose acquisition company (SPAC) formed to effect a merger with one or more businesses. It has a definitive merger agreement with HZJL Cayman Limited, a China-based provider of branding, software, and supply chain solutions to local lifestyle businesses, with the combined company expected to list on Nasdaq.

Today’s take On August 19, 2026, RDAC exploded from a $5.85 close to open at $13.39, spike intraday to $22.28, and finish at $8.78 (+50.09%) on volume of ~16.2M shares, a ~63x surge versus the prior-day volume of just 679 shares. The catalyst was an extreme low-float squeeze: the public float is only ~802,240 shares and the relative strength index reached 70.6. Investing.com explicitly described the move as a 'low-float squeeze' with no fresh company announcement, and the stock was trading +226% pre-market. Recent institutional stakes disclosed by D.E. Shaw (~4.6-8%) and Glazer Capital (~5.5%) plus the shareholders' approval of the HZJL merger (with deadline extended to August 15, 2026) fueled speculative momentum. The stock was halted intraday due to volatility and traded to $10.00 in after-hours. This was primarily momentum/short-covering in an extremely thin float rather than a confirmed fundamental catalyst.

4/10 UUU UUU +38.05%

Close 6.24 · Vol 243.6K · Type: Other

UUU UUU
Approx. 1-month price (illustrative)

Business Universal Safety Products, Inc. (NYSE American: UUU, formerly Universal Security Instruments, Inc.) is a Maryland-based micro-cap company that designs and markets a variety of popularly priced safety products nationwide, including smoke alarms, carbon monoxide alarms and related accessories sold under the UNIVERSAL and USI Electric brands. Through wholly owned Universal DeFi LLC, it also runs nodes/validator on the Ault Blockchain and is developing an asset tokenization platform.

Today’s take UUU surged 38.05% to $6.24 on Aug 19, 2026, capping a 3-day run from $3.45 (Aug 14 close) to $6.24 (~81% cumulative gain). The primary catalyst was the SEC Form 4 (filed 8/19) showing director and 10% owner Milton C. Ault III made open-market purchases totaling $201,392 between Aug 17-19 (prices $3.83-$5.87). On Aug 19 alone he bought 24,328 shares via Ault Lending at $5.5768 VWAP, plus 1,500 shares direct at $4.53 and 1,000 shares direct at $5.87 (range $5.80-$5.94) - accumulating into the very session the stock gained 38%. This confident insider accumulation, combined with an ultra-low float (~1.52M shares) and ~1.99% short interest (30.31K shares), produced a classic micro-cap scarcity squeeze; volume of ~241K represented roughly 9x the ~26K average. Context supports the move: on Aug 6 the company filed 8-K amending Articles to raise authorized common shares from 20M to 525M and eliminate super-majority voting, and its Universal DeFi subsidiary announced a tokenization platform on July 7. Since need_VolumeAnalysis=no, volume note is omitted.

5/10 SKK SKK +36.43%

Close 5.73 · Vol 7.80M · Type: Other

SKK SKK
Approx. 1-month price (illustrative)

Business SKK Holdings Limited is a Cayman Islands-incorporated company listed on the Nasdaq Capital Market (ticker: SKK). Through its wholly-owned subsidiary SKK Works Pte. Ltd., it is a civil engineering service provider specializing in subsurface utility works (horizontal directional drilling and utility installation) in Singapore, with over a decade of experience in public infrastructure projects. It is also advancing a shareholder-approved US$258.8 million acquisition of Rantizo, Inc.'s drone-based technology assets.

Today’s take On August 19, 2026, SKK Holdings announced via GlobeNewswire that its subsidiary SKK Works had been awarded six new horizontal directional drilling (HDD) and utility works contracts in Singapore valued at up to US$26.6 million (S$34.1 million) — the largest block of new work the company has ever announced. Five fixed-price subcontracts total ~US$19.6 million from civil engineering contractors and a leading telecom network operator, plus a ~US$7.0 million fixed-price subcontract tied to a Singapore statutory board project. The stock traded from an open of $4.82 to an intraday high of $8.81 before closing at $5.73, up 36.43%, on ~7.7 million shares — roughly 400x the normal daily volume near 20K shares. This came against the backdrop of a just-closed US$3.43M USDT-funded registered direct offering (Aug 17, 2026 at $4.46/share) and the pending US$258.8M Rantizo drone asset acquisition, which together drove intense retail/momentum demand on a micro-float of ~1.35M shares.

6/10 PURR PURR +30.42%

Close 9.39 · Vol 58.90M · Type: Sector

PURR PURR
Approx. 1-month price (illustrative)

Business Hyperliquid Strategies Inc. (NASDAQ: PURR) is a digital asset treasury company (DAT) based in New York that offers US and institutional investors public-market exposure to the HYPE token, the native asset of the Hyperliquid perpetuals-trading blockchain. It is the largest HYPE-focused treasury vehicle, holding roughly 22.3 million HYPE tokens.

Today’s take On August 19, 2026, President Trump hosted technology executives and federal agency chairs at the White House and stated that CFTC Chair Michael Selig is 'working to bring Hyperliquid into the United States in a fully compliant and legal fashion.' As the primary directly-listed US equity proxy for HYPE exposure, PURR surged 30.4% to close at $9.39 (from $7.20). HYPE jumped ~17% to ~$69.75, and HYPE-exposed ETFs (THYP, BHYP, HYPG) rose ~20%. The same session, Coinbase integrated Hyperliquid's perp engine into its Base App, granting eligible non-US users access to 290+ markets with up to 50x leverage. Run-up support included Druckenmiller's Duquesne Family Office disclosing a new $23M PURR position and Renaissance Technologies adding ~2.4M shares (~$18.7M). Trump also urged Congress to pass the Clarity Act.

7/10 MRVI MRVI +25.78%

Close 7.22 · Vol 15.10M · Type: Clinical

MRVI MRVI
Approx. 1-month price (illustrative)

Business Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a San Diego-based life sciences company providing critical products and services that enable drug therapy development, diagnostics, and vaccine production. Its flagship brands include TriLink BioTechnologies (with the CleanCap mRNA capping technology and nucleotide synthesis), Cygnus (biologics safety testing), Glen Research, and Alphazyme, serving a large share of the world's top biopharma R&D spenders.

Today’s take MRVI surged +25.78% to $7.22 on Aug 19, 2026, on volume of ~15.07M shares versus ~1.7M the prior day (~8.8x), setting a 52-week high of $7.70 intraday. The move was driven by Merck and Moderna's positive Phase 3 INTerpath-001 results for intismeran autogene (personalized mRNA cancer vaccine with Keytruda), which met RFS and DMFS endpoints in resected stage IIB-IV melanoma — the first positive Phase 3 readout for individualized neoantigen therapy. As a leading supplier of mRNA manufacturing reagents (CleanCap, nucleotides), Maravai rallied alongside the mRNA supply chain (BNTX +20%, RGEN +6%, NVAX +6%). Stifel called the readout 'conceptually good' for MRVI, Wells Fargo listed MRVI among key beneficiaries, and Leerink noted the sector validation. MRVI has no direct stake in the trial but benefits from expanded mRNA manufacturing demand beyond COVID as analysts noted validation should spur further investment.

8/10 ARCT ARCT +25.21%

Close 10.28 · Vol 5.60M · Type: Squeeze / float

ARCT ARCT
Approx. 1-month price (illustrative)

Business Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is a late-stage clinical mRNA medicines company developing self-amplifying mRNA vaccines (KOSTAIVE COVID-19) and treatments for rare liver and respiratory diseases, including ARCT-810 for OTC deficiency and ARCT-032 for cystic fibrosis.

Today’s take ARCT surged +25.21% to $10.28 on Aug 19, 2026 on 5.57M shares (~10x the ~500-700K average), continuing a post-Q2 earnings rally (+21.9% on Aug 7). No single new fundamental catalyst emerged; the move was driven by a powerful short squeeze dynamic. Short interest stood at ~7.21M shares (25.36% of outstanding, 27.56% of float) with 13.49 days to cover, while Benzinga pegged short float at 31.5%. Options flow was extremely bullish with 3,007 calls vs 61 puts (P/C ratio 0.02) on Aug 19. The stock gapped up ~14.6% at the open ($9.41 vs $8.21 close), traded to a high of $11.10 (Robinhood shows $13.37 intraday). This followed Q2 beat (EPS -$0.84 vs -$1.07 consensus) with cash runway to end-2028, regained global KOSTAIVE rights, and upcoming pipeline catalysts: SSIEM 2026 presentation Aug 25-28 (OTC deficiency) and ARCT-810 Phase II data/regulatory plan in Q3 2026. Analyst consensus remains Buy with avg PT ~$20-33.

9/10 TEM TEM +24.09%

Close 61.25 · Vol 22.40M · Type: Sector

TEM TEM
Approx. 1-month price (illustrative)

Business Tempus AI, Inc. is a Chicago-based technology and precision-medicine company that applies artificial intelligence to healthcare, primarily oncology. Its Nasdaq-traded shares (TEM) support a platform spanning genomic diagnostics (NGS testing), multimodal clinical and genomic data, and AI-enabled decision-support tools for cancer care.

Today’s take On 2026-08-19, TEM surged +24.09% to $61.25, driven by a third-party clinical catalyst. Merck (MRK) and Moderna (MRNA) announced positive Phase 3 INTerpath-001 topline results for intismeran autogene (V940/mRNA-4157) plus KEYTRUDA in resected stage IIB-IV melanoma, meeting primary RFS and key secondary DMFS endpoints — the first positive Phase 3 readout for an individualized neoantigen therapy and an mRNA-based cancer treatment. Investors connected this landmark win to Tempus's pending ~$1.5B acquisition of Personalis (announced ~month earlier), whose NeXT Personal ultra-sensitive MRD liquid biopsy (tracking ~1,800 patient-specific variants at parts-per-million sensitivity) underpins the tumor-sequencing approach used in the trial. Short interest stood near ~28-30M shares (~28% of float), amplifying the move into a technical short squeeze. Backdrop: Tempus posted its first GAAP-profitable quarter (Q2 2026 revenue $382.5M, +22% YoY) and raised 2026 revenue guidance to ~$1.595-1.605B (~25% growth). 12-month price target avg $62.64 (16 analysts).

10/10 NIPG NIPG +23.20%

Close 14.71 · Vol 155.3K · Type: Sector

NIPG NIPG
Approx. 1-month price (illustrative)

Business NIP Group Inc. (NASDAQ: NIPG) is a Cayman Islands-incorporated holding company headquartered in Abu Dhabi, UAE, operating at the nexus of Bitcoin mining, compute infrastructure, and global digital entertainment. The company pivoted into Bitcoin mining in 2025, reaching 9.66 EH/s of hash rate capacity by January 2026, producing ~151.4 BTC in its first operating period.

Today’s take On August 19, 2026, NIPG surged 23.20% to $14.71 from a prior close of $11.94, with volume of 155,300 shares vs. a 20-day average of ~62,352 (roughly 2.5x elevated). The move was driven by a broad crypto-market rally: Bitcoin broke above $69,000 (first time in two months, up ~6.7% in 24h) after the U.S. Treasury announced it would at least double liquidity-support buybacks for longer-dated bonds (from $2B to ≥$4B per operation, effective Sept 9), the SEC proposed a 'Regulation Crypto Assets' framework creating two exemptions for crypto investment contract issuers, and a White House meeting between crypto executives and President Trump was scheduled. The rally triggered ~$1.92B in crypto liquidations. NIPG, which has pivoted heavily into Bitcoin mining (9.66 EH/s capacity, targeting 11.3 EH/s and ~140 BTC/month), tracked broader crypto-linked equities — Strategy (MSTR) rose ~10%, Fold (FLD) ~20%, Coinbase (COIN) ~12%. Intraday, NIPG ranged from $11.00 low to $16.39 high (~45% amplitude), reflecting speculative momentum and short-squeeze dynamics beyond the fundamental catalyst.

1/10 PFSA PFSA -50.62%

Close 13.57 · Vol 1.40M · Type: Other

PFSA PFSA
Approx. 1-month price (illustrative)

Business Profusa, Inc. (Nasdaq: PFSA) is a commercial-stage digital health/medical technology company based in Berkeley, California, developing bioengineered, tissue-integrated biosensors that continuously detect and transmit medical-grade biochemical data. Its principal Lumee Tissue Oxygen Monitoring Platform targets peripheral artery disease, chronic wounds and reconstructive surgery, with a pipeline Lumee Glucose Platform in development.

Today’s take The -50.62% drop on Aug 19, 2026 to $13.57 is best read as the unwind of an extreme post-reverse-split speculative spike rather than a fresh fundamental shock. On the prior session (Aug 18), after Profusa's 1-for-4 reverse split became effective (its third of 2026, following 1-for-75 on Feb 9 and 1-for-25 on Jul 7), the stock soared +506.62% to $27.48 on an ultra-thin float (shares outstanding ~46,602; float ~45,464; market cap ~$632K). On Aug 19 the speculative bid collapsed, the stock falling ~51% amid 1.43M shares traded (day range $11.71-$17.58). Confluence catalyst: on Aug 19 the company's Q2 FY26 Form 10-Q disclosed a widened GAAP net loss of $8.76M (vs $2.35M a year earlier) and cash drained to $0.7M from $1.8M at end-2025, accelerating profit-taking in the microfloat. Trading was also halted 'news pending' around the event, compounding volatility in a name that has fallen ~99.7% over 52 weeks.

2/10 IPST IPST -46.38%

Close 8.45 · Vol 1.90M · Type: Squeeze / float

IPST IPST
Approx. 1-month price (illustrative)

Business IP Strategy Holdings, Inc. (Nasdaq: IPST), formerly Heritage Distilling Holding Company, is a diversified holding company focused on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits segment. It holds $IP/$DATA tokens in its treasury reserve as direct participation in the Story/Story Protocol ecosystem (on-chain IP registration, licensing and monetization) and operates validator infrastructure for the network, with headquarters in Gig Harbor, Washington.

Today’s take IPST closed at $8.45 on Aug 19, 2026, down -46.38% (-$7.31), the violent third leg of a low-float parabolic episode. After trading around $1.90-$2.60 for months, the stock exploded +235.89% on Aug 17 (close $7.39, volume 100.9M) and +113.26% on Aug 18 (close $15.76, 31.6M shares), driven by a micro-float (~664K public float) momentum/short-squeeze frenzy linked to its Story Protocol $IP crypto-token exposure and the ~$80T programmable-IP narrative. On Aug 19 it opened at $16.17, spiked to a $16.48 high, then collapsed to a $7.69 low before closing at $8.45, with a NASDAQ volatility trading halt/resume around 09:42-09:59 EDT. Volume of ~1.88M shares represented roughly 3x the entire public float. A contextual fundamental overhang: on Aug 17 the company filed a Form 12b-25 delaying its Q2 10-Q, disclosing a preliminary Q2 net loss of $13.8M-$17.8M (vs ~$7.3M a year earlier) and revenue collapsing to $0.39M-$0.5M from $1.3M, amplifying the unwind.

3/10 KWM KWM -37.88%

Close 1.64 · Vol 1.00M · Type: Other

KWM KWM
Approx. 1-month price (illustrative)

Business K Wave Media Ltd. (Nasdaq: KWM), formerly K Enter Holdings, is a Nasdaq-listed company focused on pursuing strategic growth opportunities in AI infrastructure and related technologies. The micro-cap also retains an entertainment holding background (Korean content/IP) after going public via a SPAC merger with Global Star Acquisition in May 2025.

Today’s take On Aug 19, 2026 KWM announced it had regained Nasdaq minimum bid price compliance (positive), yet the same day the stock collapsed -37.88% from a $2.64 prior close to $1.64 (open $3.00, high $3.25, low $1.50) on volume of 998,868 shares — roughly 11-14x the ~70-104K daily average. The primary driver was the after-hours pricing of a $1.0M registered direct offering of 526,314 ordinary shares at $1.90/share (~13% discount to prior close), with D. Boral Capital as placement agent, closing Aug 20. This dilutive raise (roughly 20% of the ~2.6M post-split share count) created an arbitrage overhang that pressured the price intraday toward/below the offering level. Context: the 1-for-30 reverse split effective Aug 3 and expected rebrand to Nexus Advanced Technologies Inc. (ticker NXAT ~Aug 21) amplified retail attention but failed to offset dilution. The stock recovered slightly to $1.66-1.69 after hours.

4/10 WETO WETO -37.09%

Close 20.76 · Vol 964.4K · Type: Other

WETO WETO
Approx. 1-month price (illustrative)

Business Wetour Robotics Limited (NASDAQ: WETO) is a Physical AI infrastructure and wearable robotics company headquartered in Austin, Texas with its legal entity incorporated in the Cayman Islands. It develops Orchestra, a portable edge-AI operating system built on NVIDIA Jetson hardware that coordinates human intent with intelligent physical devices, and has joined the Qualcomm Partner Network.

Today’s take WETO plunged 37.09% on August 19, 2026 to close at $20.76 on 950,395 shares, capping a violent speculative cycle reversal. After completing a 1-for-100 reverse split on Aug 3 (float cut to ~820K-1.08M shares), the stock soared +199.15% on Aug 17 (to $24.59, 30.3M volume) and +34.20% on Aug 18 (to $33.00). August 19 marked an open momentum unwind with no new negative company-specific news. Instead, profit-takers fled ahead of the Aug 24 Extraordinary General Meeting, where shareholders vote on a second 100-for-1 reverse split plus an explosive authorized-share increase to 2 trillion shares (a ~200,000x jump vs. the 10M post-split standard), signaling severe dilution. The stock trades on ultra-thin float with H1 FY2026 revenue of ~$9.56M (down 45% YoY) and a net loss, no fundamentals backing the +455% two-day surge. WETO was flagged among the day's top decliners.

5/10 SNSC SNSC -35.47%

Close 1.31 · Vol 707.5K · Type: Other

SNSC SNSC
Approx. 1-month price (illustrative)

Business SunScout Holding Limited is a Cayman Islands-incorporated clean-technology company (dual-listed on NYSE American and NYSE Texas) that designs, manufactures and commercializes autonomous, solar-powered robotic lawn mowers. Its proprietary deployable solar array (DSA) technology lets mowers operate grid-independently, with operations based in New Zealand and the US (via Brightway Energy LLC).

Today’s take SNSC staged a severe post-IPO unwind. The stock priced a downsized US IPO on Aug 12, 2026 at $5.00/share (low end of $5-$6 range), raised $15.5M (3.1M shares vs original 4.0M), spiked to an all-time high of $4.40 on the listing day, then collapsed to $1.31 by Aug 19 (-35.47%), a new 52-week low ($1.27 intraday). It closed at $2.03 on Aug 18 after an uninterrupted slide. Notably, the drop coincided with a positive operational headline: the company announced on Aug 19 morning that it commenced commercial shipments of the SunScout Eco robotic mower to Europe and New Zealand (~$8.9M annualized revenue projection). The decline reflects classic 'sell-the-news'/distribution in a newly-listed speculative micro-cap: extreme valuation (P/B ~31x, PE ~65x, EV/Sales ~9.6x), thin float (10.08M shares, 58% insider-owned), and an Altman Z-score of 2.84 flagging balance-sheet risk. Market cap fell to ~$31.4M.

6/10 XOS XOS -34.68%

Close 2.90 · Vol 7.60M · Type: Other

XOS XOS
Approx. 1-month price (illustrative)

Business Xos, Inc. (NASDAQ: XOS) is a Los Angeles-based electric commercial vehicle manufacturer and fleet services provider founded in 2016. The company designs, manufactures, and sells Classes 5-8 battery-electric commercial vehicles for last-mile, back-to-base routes up to 200 miles per day, and offers the Xos Hub mobile battery energy storage system, Xos Energy Solutions charging infrastructure, and Xosphere fleet-management software.

Today’s take XOS crashed -34.68% on Aug 19, 2026, closing at $2.90 (-$1.54) on 7.44M shares, a direct profit-taking reversal of the prior session's parabolic +112.44% surge to $4.44 on 106.5M shares. On Aug 18 pre-market, the company announced a prototype Other Transaction Agreement (OTA) with the U.S. Air Force to develop a ruggedized Xos Hub mobile charging solution for electrified support equipment at Air Force bases. The contract is a prototype agreement, not a bulk purchase order, so near-term revenue contribution is minimal. Fundamentals had not changed: Q2 2026 (reported Aug 13) showed only $4.7M revenue vs $18.4M year-ago, an operating loss of $7.9M, and 2026 revenue guidance cut to $35M-$43M. The stock gapped down to $3.89, hit an intraday low of $2.84, closed at $2.90, then recovered slightly to ~$2.93 after hours, indicating orderly unwinding by momentum traders who piled in on the Air Force headline rather than new adverse news.

7/10 SLE SLE -25.09%

Close 4.12 · Vol 1.70M · Type: Other

SLE SLE
Approx. 1-month price (illustrative)

Business Super League Enterprise, Inc. (Nasdaq: SLE) is a Santa Monica, California-based gaming media and advertising company that helps brands reach consumers across gaming and digital media platforms, including Roblox, Minecraft, and Fortnite, through branded content, playable ads, and influencer campaigns. On August 18, 2026, Metaplanet announced a definitive agreement to invest 2,100 BTC (~$132.1M) plus $2.5M cash for a ~95.7% controlling stake, with the company to be renamed 'Superplanet, Inc.' (ticker: SUPA).

Today’s take SLE dropped 25.09% to $4.12 on Aug 19, 2026, following a massive 3-day speculative surge. The stock jumped 33% on Aug 17 (to $3.02), then surged 82% intraday to $7.37 high on Aug 18 after Metaplanet's 2,100 BTC (~$132.1M) investment deal, closing at $5.50 on 49.1M shares (vs ~15k typical). The Aug 19 selloff reflected post-announcement profit-taking and dilution concerns: Metaplanet receives 44.86M new shares at only $3.00/share plus warrants for up to 381M additional shares ($3.00-$33.50 strikes), giving it ~95.7% control and leaving existing shareholders ~4.3%. A $2.23M ATM offering was also filed Aug 18. Maxim Group reiterated Buy but cut price target from $15 to $12 on Aug 19. Volume collapsed to 1.7M shares, down from 49M, indicating the speculative frenzy had cooled as investors reassessed the dilutive deal terms.

8/10 TOYO TOYO -24.21%

Close 4.34 · Vol 4.80M · Type: Earnings

TOYO TOYO
Approx. 1-month price (illustrative)

Business TOYO Co., Ltd. is a Cayman Islands-incorporated solar solutions company headquartered in Tokyo, Japan, trading on Nasdaq (NasdaqCM) under ticker TOYO. The company integrates upstream silicon/wafer production, midstream solar cell manufacturing, and downstream photovoltaic module production across Asia and the United States, including a 1.5GW HJT cell facility planned in Humble, Texas.

Today’s take TOYO cratered -24.21% to $4.34 on Aug 19, 2026, the session of its Q2/H1 2026 earnings release. Q2 GAAP EPS of $0.45 missed consensus ($0.53-$0.69 ranges across sources) while revenue of $118.18M fell roughly $78-86M short of ~$196-205M estimates — a ~40% top-line shortfall, far exceeding typical quarterly variance. Although Q2 revenue grew 34.9% YoY to $118.2M, it declined sequentially from Q1 as product mix shifted from cells to modules. H1 shipments of 2.6GW cells and 191.5MW modules put the company on track to miss its own full-year guidance (5.5-5.8GW cells, 1-1.3GW modules). Management issued no FY guidance, citing regulatory uncertainty from an active AD/CVD circumvention investigation into its Ethiopian cell facility (which allegedly uses Chinese wafers), and indicated H2 results could be impacted. The stock closed just $0.01 above its $4.33 52-week low, down ~75% from a 52-week high of $17.43, with prior downward pressure from a June 24 dilutive $50M offering (-38.8% that day).

9/10 WYFI WYFI -21.02%

Close 21.38 · Vol 15.70M · Type: Other

WYFI WYFI
Approx. 1-month price (illustrative)

Business WhiteFiber, Inc. (NASDAQ: WYFI) is a provider of artificial intelligence (AI) infrastructure solutions, operating as a vertically integrated AI infrastructure company with Cloud Services and Colocation Services segments. It designs, develops, and operates high-performance computing (HPC) data centers for GPU cloud, generative-AI, and hybrid AI workloads, and is a subsidiary of Bit Digital, Inc.

Today’s take WYFI gapped down and fell 21.02% on Aug 19, 2026, closing at $21.38 from a prior close of $27.07, after the company priced an upsized $270M 5.00% convertible senior notes offering due 2032 (raised from $250M, with a $40M additional purchase option). The initial conversion price of ~$33.84 was set at a 25% premium to the Aug 18 close, signaling future equity dilution. Concurrently, WhiteFiber exchanged $198.15M of its existing 4.50% notes due 2031 for ~$118.5M cash plus ~6.3M new shares, and hedgers unwinding positions/selling received shares pressured the stock. Investors.com cited the plunge (25% reported) in the context of AI/data-center firms accumulating massive debt; WYFI carried $25.5M long-term debt plus $222.6M convertible notes payable in Q2. The proceeds fund NC data-center acquisitions (NC-2, NC-3, $60M purchase, ~60-200MW), GPU servers, and power agreements, though management said additional construction financing is still needed. Sector-wide skepticism over leveraged AI balance sheets amplified the selling. After-hours volume 15,646,528 shares (5-10x recent ~1.3-3.3M) confirmed institutional/funding-driven capitulation despite retail turning 'extremely bullish'.

10/10 CAST CAST -19.05%

Close 1.70 · Vol 41.80M · Type: High volume

CAST CAST
Approx. 1-month price (illustrative)

Business FreeCast, Inc. (NASDAQ: CAST) is a streaming media technology company based in Orlando, Florida, providing cloud-based Platform-as-a-Service (PaaS) solutions, content aggregation, advertising, and digital distribution technologies. The company was publicly listed via a direct listing on the Nasdaq Global Market on March 10, 2026, opening at $33 per share.

Today’s take On August 19, 2026, CAST fell -19.05% ($2.10 to $1.70) on 41.6 million shares, a textbook profit-taking / mean-reversion session following a parabolic +144.24% surge the prior day (Aug 18: $0.86 to $2.10 on 147M shares) triggered by FreeCast's announcement of full acquisition of the Investor News Channel and plans to relaunch it as a 24/7 global financial FAST network in November 2026. On Aug 19, the stock opened higher at $2.22, spiked to $2.39, then sold off steadily to close at $1.70 with an additional -10.59% drop in after-hours to ~$1.52. No fresh company-specific negative news hit the tape that day; the decline was driven by speculative momentum exhaustion and distribution by short-term traders. Underlying fundamentals remain extremely weak: Fugazi Research's June 2026 short report (worth $0 thesis) cited only $92,909 in Q1 2026 revenue versus $4.5M+ quarterly losses, a $119K cash balance, $205.4M accumulated deficit, and a going-concern warning. CAST remains down ~90% from its $33.00 direct-listing opening price, with a 52-week range of $0.50-$33.00.